ICYMI, some of this week’s featured content includes an exclusive interview about the unmet needs of vitiligo patients, and articles on international impetigo guidelines, the newly released tapinarof data, and more.
Seemal Desai, MD, FAAD, and William Damsky, MD, PhD, discuss methods for managing a patient’s motivation and expectations when on therapy for vitiligo.
A recent JAAD study evaluated the correlation between F-VASI and T-VASI using patient- and physician-reported measures of clinical improvement, PaGIC-V and PhGVA.
A brief review of the treatment armamentarium for vitiligo, as well as the prevalent unmet needs in that setting.
A study examined the impact of virtual group visits to obtain community and education for pediatric vitiligo and alopecia areata patients and caregivers.
In this week’s Pointers with Dr Portela, the 208SkinDoc answers viewer questions about acne scarring including how to distinguish between acne scars and inflammatory pigment change.
A new study on the gender pay gap in medicine examined earnings data from more than 80,000 doctors.
The New England Journal of Medicine has published the clinical trial data from the PSOARING 1 and PSOARING 2 studies on tapinarof treatment for plaque psoriasis.
Telehealth visits increased, but overall utilization of Part B declined.
Impetigo is a common skin infection in which ozenoxacin may be used as a treatment. This study aimed to evaluate the safety and efficacy of the therapy in pediatric patients compared to other topical treatments.
A recent systematic review of guidelines of the management of impetigo was published in the Family Practice Journal.
Here is what to expect from the “Getting to the Roots of Childhood Acne” live virtual webinar happening December 15 at 6:30 p.m.
A new study in the Journal of General Internal Medicine finds compliance remains lacking a year after federal price transparency rules went into effect.
Seborrheic dermatitis will affect roughly half of all infants, making knowing how to treat and manage it key.